Title of article :
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 yearsʹ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Author/Authors :
Raimund Jakesz، نويسنده , , Walter Jonat، نويسنده , , Michael Gnant، نويسنده , , Martina Mittlboeck، نويسنده , , Richard Greil، نويسنده , , Christoph Tausch، نويسنده , , Joern Hilfrich، نويسنده , , Werner Kwasny، نويسنده , , Christian Menzel، نويسنده , , Hellmut Samonigg، نويسنده , , Michael Seifert، نويسنده , , Guenther Gademann، نويسنده , , Manfred Kaufmann، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Pages :
8
From page :
455
To page :
462
Abstract :
Background Tamoxifen has been the standard adjuvant treatment for postmenopausal women with hormone-responsive early breast cancer for more than 20 years. However, the third-generation aromatase inhibitor anastrozole has proven efficacy and tolerability b
Journal title :
The Lancet
Serial Year :
2006
Journal title :
The Lancet
Record number :
588484
Link To Document :
https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=588484
بازگشت